GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds
In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase
Colorado Governor Signs Bill Mandating Reimbursement For Mammography Screening
Wisconsin Group Takes Lead In Challenging Pain Control Perception
Rich Left AMC “For Personal Reasons”
Black Physicians, Community Group To work With NCI
Reimbursement Policy By Philadelphia Blue Cross Further Explained
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
